WCG Pharmaseek LLC

King Pharmaceuticals is a vertically integrated pharmaceutical firm that develops, manufactures, markets and sells therapies and technologies for cardiovascular, metabolics, neuroscience, and hospital and acute care. The company has unique strengths in commercialization, advanced clinical development, manufacturing and regulatory affairs. It features various late-stage compounds and branded prescription products and technologies. King s product line includes Altace, Skelaxin, Sonata, Levoxyl, Synercid and auto-injector solutions. The company s facilities produce a range of dosage forms, such as tablets, capsules, liquids, suspensions, solutions, suppositories, creams, ointments and injectables. It is listed on the S&P 500 Index. King Pharmaceuticals operates manufacturing facilities in Bristol, Tenn., Rochester, Mich., St. Louis, St. Petersburg, Fla., and Middleton, Wis.

Arkayli Biopharma, based in Madison, WI, is dedicated to developing innovative medications utilizing precision drug delivery systems aimed at enhancing treatment efficacy and safety for individuals with vascular anomalies. Their lead product candidate, ARK001, is positioned to be the first FDA-approved non-systemic topical treatment for infantile hemangioma, offering a new approach to care that allows for earlier intervention by pediatricians and dermatologists. ARK001 is designed to provide a safe and effective localized treatment that minimizes systemic exposure, requiring only a single daily application to deliver 24-hour relief. The formulation is user-friendly, easily washing off with mild soap and water after a day, making it convenient for infants, their families, and caregivers. Generated from the website